The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 348:1497-1498 April 10, 2003 Number 15
NextNext

Giant-Cell Arteritis

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Salvarani, C.
-PubMed Citation
To the Editor: In their review of polymyalgia rheumatica and giant-cell arteritis, Salvarani and colleagues (July 25 issue)1 describe the ocular manifestations of giant-cell arteritis, including funduscopic findings. We believe there is an important omission because uveitis is not mentioned.

Visual involvement occurs in 25 to 50 percent of patients with giant-cell arteritis. Loss of vision due to ischemia of the optic nerve is the most well known of these complications.2 Uveitis is an uncommon presenting feature of giant-cell arteritis and is due to ischemia of the posterior ciliary arteries and their branches.3,4 Posterior uveitis is manifested as choroidal ischemic . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.